Recurrent Loss of STING Signaling in Melanoma Correlates with Susceptibility to Viral Oncolysis

Overview of attention for article published in Cancer Research, November 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 3 X users

patent: 20 patents

Readers on

mendeley: 249 Mendeley

So far, Altmetric has seen 20 patents that reference this research output.

Enhancing anti-tumor response in melanoma cells with defective sting signaling

Grant US-12599621-B2

United States of America

14 Apr 2026

SYNTHESIS OF DRUG-LINKER COMBINATIONS FOR ANTIBODY-DRUG CONJUGATES

Application WO-2026044149-A2

World Intellectual Property Organisation (WIPO)

26 Feb 2026

Compositions of polymeric microdevices and methods of use thereof in cancer immunotherapy

Grant US-12390537-B2

United States of America

19 Aug 2025

Methods for the treatment of bladder cancer

Grant US-12251394-B2

United States of America

18 Mar 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 16 additional patents.